Clinical Trials List
Phase
Status
Clinical Trials List
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | Details |
|---|---|---|---|---|---|---|---|
| c1381 | NCT00446849 | PHASE4 | Completed | YES | May 2007 | August 17, 2009 | Details |
| c1382 | NCT02636517 | PHASE1 | Enrolling_by_invitation | NO | December 2025 | December 27, 2025 | Details |
| c1383 | NCT02171429 | PHASE3 | Completed | YES | November 2014 | May 25, 2020 | Details |
| c1384 | NCT02466217 | -- | Completed | NO | July 2015 | July 18, 2022 | Details |
| c1385 | NCT02163759 | PHASE3 | Completed | YES | November 2014 | March 19, 2020 | Details |
| c1386 | NCT04909359 | -- | Completed | NO | August 2015 | May 18, 2020 | Details |
| c1387 | NCT06080048 | PHASE1 | Completed | NO | October 2023 | November 8, 2024 | Details |
| c1388 | NCT03558152 | PHASE2 | Completed | YES | October 2018 | December 15, 2021 | Details |
| c1389 | NCT01177228 | PHASE2 | Completed | YES | May 2025 | September 8, 2025 | Details |
| c1390 | NCT01456052 | PHASE2 | Completed | YES | January 2012 | September 3, 2013 | Details |
| c1391 | NCT02100696 | PHASE3 | Completed | YES | May 2014 | April 16, 2020 | Details |
| c1392 | NCT02520284 | PHASE2|PHASE3 | Terminated | YES | September 2025 | November 16, 2025 | Details |
| c1393 | NCT01257399 | PHASE3 | Completed | NO | November 2025 | March 13, 2025 | Details |
| c1394 | NCT01336465 | PHASE2 | Completed | NO | September 2025 | June 13, 2025 | Details |
| c1395 | NCT01517594 | -- | Completed | NO | October 2025 | June 13, 2025 | Details |
| c1396 | NCT05386290 | -- | Unknown Status | NO | July 2020 | December 23, 2025 | Details |
| c1397 | NCT04564638 | -- | Completed | NO | March 2015 | September 1, 2019 | Details |
| c1398 | NCT06696014 | -- | Not_yet_recruiting | NO | December 2025 | January 30, 2025 | Details |
| c1399 | NCT02118584 | PHASE3 | Terminated | YES | September 2014 | October 5, 2023 | Details |
| c1400 | NCT01882764 | PHASE3 | Terminated | YES | June 2025 | October 14, 2025 | Details |